Assessing pulmonary hypertensive vascular disease in childhood data from the Spanish registry

American Journal of Respiratory and Critical Care Medicine

Volumn 190, Issue 12, 2014, Pages 1421-1429

  Maŕin, M J Del Cerro ^a   Rotés, A Sabate ^b   Ogando, A Rodriguez ^c   Soto, A Mendoza ^d   Jiménez, M Quero ^a   Camacho, J L Gavilán ^e   Sonnenfeld, I Raposo ^f   Bonora, A Moya ^g   Brotons, D C Albert ^b   Galdó, A Moreno ^b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^d HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^f HOSPITAL JUAN CANALEJO   (Spain)

^g HOSPITAL INFANTIL LA FE   (Spain)

Author keywords

Epidemiology; Pediatrics; Pulmonary hypertension; Registries; Survival

Indexed keywords

ARTICLE; CHILD; CHILDHOOD DISEASE; FEMALE; HEART DISEASE; HEART RIGHT ATRIUM PRESSURE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; RESPIRATORY TRACT DISEASE; RISK FACTOR; SPAIN; SURVIVAL RATE; THROMBECTOMY; ADOLESCENT; AGE; HYPERTENSION, PULMONARY; INCIDENCE; INFANT; MORTALITY; PRESCHOOL CHILD; PREVALENCE; REGISTER; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPERTENSION, PULMONARY; INCIDENCE; INFANT; MALE; PREVALENCE; REGISTRIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPAIN;

EID: 84919360638     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201406-1052OC     Document Type: Article

References (41)

1. Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, Gomez Sanchez MA, Krishna Kumar R, Landzberg M, Machado RF, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013;62(Suppl. 25): D34-D41.
2. Cerro MJ, Abman S, Diaz G, Freudenthal AH, Freudenthal F, Harikrishnan S, Haworth SG, Ivy D, Lopes AA, Raj JU, et al. A consensus approach to the classification of pediatric pulmonary hypertensive vascular disease: Report from the PVRI Pediatric Taskforce, Panama 2011. Pulm Circ 2011;1: 286-298.
3. Ivy DD, Abman SH, Barst RJ, Berger RM, Bonnet D, Fleming TR, Haworth SG, Raj JU, Rosenzweig EB, Schulze Neick I, et al. Pediatric pulmonary hypertension. J Am Coll Cardiol 2013;62(Suppl. 25): D117-D126.
4. Van Loon RL, Roofthooft MT, van Osch-Gevers M, Delhaas T, Strengers JL, Blom NA, Backx NA, Berger RM. Clinical characterization of pediatric pulmonary hypertension: Complex presentation and diagnosis. J Pediatr 2009;155: 176-182.e1.
5. van Loon RL, Roofthooft MT, Hillege HL, ten Harkel AD, van Osch-Gevers M, Delhaas T, Kapusta L, Strengers JL, Rammeloo L, Clur SA, et al. Pediatric pulmonary hypertension in the Netherlands: Epidemiology and characterization during the period 1991 to 2005. Circulation 2011;124: 1755-1764.
6. Moledina S, Hislop AA, Foster H, Schulze-Neick I, Haworth SG. Childhood idiopathic pulmonary arterial hypertension: A national cohort study. Heart 2010;96: 1401-1406.
7. Haworth SG, Hislop AA. Treatment and survival in children with pulmonary arterial hypertension: The UK Pulmonary Hypertension Service for Children 2001-2006. Heart 2009;95: 312-317.
8. Barst RJ, McGoon MD, Elliott CG, Foreman AJ, Miller DP, Ivy DD. Survival in childhood pulmonary arterial hypertension: Insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management. Circulation 2012;125: 113-122.
9. Fraisse A, Jais X, Schleich JM, di Filippo S, Maragne s P, Beghetti M, Gressin V, Voisin M, Dauphin C, Clerson P, et al. Characteristics and prospective 2-year follow-up of children with pulmonary arterial hypertension in France. Arch Cardiovasc Dis 2010;103: 66-74.
10. Berger RM, Beghetti M, Humpl T, Raskob GE, Ivy DD, Jing ZC, Bonnet D, Schulze-Neick I, Barst RJ. Clinical features of paediatric pulmonary hypertension: A registry study. Lancet 2012;379: 537-546.
11. Cerro MJ, SabatéA, Quero M, Raposo I, Moya A, VillagráS; REHIPED investigators. Outcomes of pediatric pulmonary hypertension. Data from the Spanish Registry for Pediatric Pulmonary Hypertension (REHIPED). Presented as oral communication at the 6th World Congress on Pediatric Cardiology and Cardiac Surgery, Cape Town, 17-2 Febrero 2013. Cardiovasc J Africa 2013;24: 180.
12. Cerro MJ, Moreno A, Sabate A, Viadero M, Izquierdo MA, Dominguez O, Falcon H; REHIPED investigators. Management and clinical features of paediatric pulmonary arterial hypertension in Spain: Data from the Spanish Registry for Paediatric Pulmonary Hypertension (REHIPED). Presented as e-poster at the 6th World Congress on Pediatric Cardiology and Cardiac Surgery, Cape Town, 17-2 Febrero 2013 [abstract]. Cardiovasc J Africa 2013;24: 180.
13. Cerro MJ, Albert D, Gavilan JL, Gomez E, Lopez M, Espin J, Escribano P. REHIPED/REHAP investigators epidemiology of pulmonary arterial hypertension in a Spanish paediatric population: Data from the Spanish Registry for Paediatric Pulmonary Hypertension (REHIPED) and Spanish Registry for Pulmonary Arterial Hypertension in Adults (REHAP). Presented as e-poster at the 6th World Congress on Pediatric Cardiology and Cardiac Surgery, Cape Town, 17-2 Febrero 2013 [abstract]. Cardiovasc J Africa 2013;24: 183.
14. Escribano-Subias P, Blanco I, López-Meseguer M, Lopez-Guarch CJ, Roman A, Morales P, Castillo-Palma MJ, Segovia J, Gómez-Sanchez MA, Barbera JA; REHAP investigators. Survival in pulmonary hypertension in Spain: Insights from the Spanish Registry. Eur Respir J 2012;40: 596-603.
15. Levy M, Celermajer D, Szezepanski I, Boudjemline Y, Bonnet D. Do tertiary paediatric hospitals deal with the same spectrum of paediatric pulmonary hypertension as multicentre registries? Eur Resp J 2013;42: 689-700.
16. Poms AD, Turner M, Farber HW, Meltzer LA, McGoon MD. Comorbid conditions and outcomes in patients with pulmonary arterial hypertension: A REVEAL registry analysis. Chest 2013;144: 169-176.
17. Beghetti M, Berger RM, Schulze-Neick I, Day RW, Pulido T, Feinstein J, Barst RJ, Humpl T; TOPP Registry Investigators. Diagnostic evaluation of paediatric pulmonary hypertension in current clinical practice. Eur Respir J 2013;42: 689-700.
18. Moledina S, Pandya B, Bartsota M, Mortensen KH, McMillan M, Quyam S, Taylor AM, Haworth SG, Schulze-Neick I, Muthurangu V. Prognostic significance of cardiac magnetic resonance imaging in children with pulmonary hypertension. Circ Cardiovasc Imaging 2013;6: 407-414.
19. Wilkens H, Lang I, Behr J, Berghaus T, Grohe C, Guth S, Hoeper MM, Kramm T, Krüger U, Langer F, et al. Chronic thromboembolic pulmonary hypertension (CTEPH): Updated Recommendations of the Cologne Consensus Conference 2011. Int J Cardiol 2011;154: S54-S60.
20. Manlhiot C, Menjak IB, Brandão LR, Gruenwald CE, Schwartz SM, Sivarajan VB, Yoon H, Maratta R, Carew CL, McMullen JA, et al. Risk, clinical features, and outcomes of thrombosis associated with pediatric cardiac surgery. Circulation 2011;124: 1511-1519.
21. Agha BS, Sturm JJ, Simon HK, Hirsh DA. Pulmonary embolism in the pediatric emergency department. Pediatrics 2013;132: 663-667.
22. Taylor CJ, Derrick G, McEwan A, Haworth SG, Sury MR. Risk of cardiac catheterization under anaesthesia in children with pulmonary hypertension. Br J Anaesth 2007;98: 657-661.
23. Carmosino MJ, Friesen RH, Doran A, Ivy DD. Perioperative complications in children with pulmonary hypertension undergoing noncardiac surgery or cardiac catheterization. Anesth Analg 2007;104: 521-527.
24. Hill KD, Lim DS, Everett AD, Ivy DD, Moore JD. Assessment of pulmonary hypertension in the pediatric catheterization laboratory: Current insights from the Magic registry. Catheter Cardiovasc Interv 2010;76: 865-873.
25. Sitbon O, Humbert M, Nunes H, Parent F, Garcia G, HervéP, Rainisio M, Simonneau G. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: Prognostic factors and survival. J Am Coll Cardiol 2002;40: 780-788.
26. Barst RJ, Ivy DD, Foreman AJ, McGoon MD, Rosenzweig EB. Four-And seven-year outcomes of patients with congenital heart disease-Associated pulmonary arterial hypertension (from the REVEAL Registry). Am J Cardiol 2014;113: 147-155.
27. Burch M, Kaufman L, Archer N, Sullivan I. Persistent pulmonary hypertension late after neonatal aortic valvotomy: A consequence of an expanded surgical cohort. Heart 2004;90: 918-920.
28. Robinson JD, Del Nido PJ, Geggel RL, Perez-Atayde AR, Lock JE, Powell AJ. Left ventricular diastolic heart failure in teenagers who underwent balloon aortic valvuloplasty in early infancy. Am J Cardiol 2010;106: 426-429.
29. Tuo G, Khambadkone S, Tann O, Kostolny M, Derrick G, Tsang V, Sullivan I, Marek J. Obstructive left heart disease in neonates with a "borderline" left ventricle: Diagnostic challenges to choosing the best outcome. Pediatr Cardiol 2013;34: 1567-1576.
30. Oliver JM, Gallego P, Gonzalez AE, Sanchez-Recalde A, Bret M, Aroca A. Pulmonary hypertension in young adults with repaired coarctation of the aorta: An unrecognised factor associated with premature mortality and heart failure. Int J Cardiol 2014;174: 324-329.
31. Bhat R, Salas AA, Foster C, Carlo WA, Ambalavanan N. Prospective analysis of pulmonary hypertension in extremely low birth weight infants. Pediatrics 2012;129: E682-e689.
32. Khemani E, McElhinney DB, Rhein L, Andrade O, Lacro RV, Thomas KC, Mullen MP. Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: Clinical features and outcomes in the surfactant era. Pediatrics 2007;120: 1260-1269.
33. del Cerro MJ, SabatéRotés A, Cartón A, Deiros L, Bret M, Cordeiro M, VerdúC, Barrios MI, Albajara L, Gutierrez-Larraya F. Pulmonary hypertension in bronchopulmonary dysplasia: Clinical findings, cardiovascular anomalies and outcomes. Pediatr Pulmonol 2014;49: 49-59.
34. Clement A, Eber E. Interstitial lung diseases in infants and children. Eur Respir J 2008;31: 658-666.
35. del Toro M, Arranz JA, Macaya A, Riudor E, Raspall M, Moreno A, Vazquez E, Ortega A, Matsubara Y, Kure S, et al. Progressive vacuolating glycine leukoencephalopathy with pulmonary hypertension. Ann Neurol 2006;60: 148-152.
36. Menéndez Suso JJ, Del Cerro Maŕin MJ, Dorao Martínez-Romillo P, Labrandero de Lera C, Fernández Garćia-Moya L, Rodŕiguez González JI. Nonketotic hyperglycinemia presenting as pulmonary hypertensive vascular disease and fatal pulmonary edema in response to pulmonary vasodilator therapy. J Pediatr 2012;161: 557-559.
37. Navarro-Sastre A, Tort F, Stehling O, Uzarska MA, Arranz JA, Del Toro M, Labayru MT, Landa J, Font A, Garcia-Villoria J, et al. A fatal mitochondrial disease is associated with defective NFU1 function in the maturation of a subset of mitochondrial Fe-S proteins. Am J Hum Genet 2011;89: 656-667.
38. Hurdman J, Condliffe R, Elliot CA, Davies C, Hill C, Wild JM, Capener D, Sephton P, Hamilton N, Armstrong IJ, et al. ASPIRE registry: Assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre. Eur Respir J 2012;39: 945-955.
39. Barst RJ, Maislin G, Fishman AP. Vasodilator therapy for primary pulmonary hypertension in children. Circulation 1999;99: 1197e208
40. Yung D, Widlitz AC, Rosenzweig EB, Kerstein D, Maislin G, Barst RJ. Outcomes in children with idiopathic pulmonary arterial hypertension. Circulation 2004;110: 660-665.
41. Sandoval J, Bauerle O, Gomez A, Palomar A, Martínez Guerra ML, Furuya ME. Primary pulmonary hypertension in children: Clinical characterization and survival. J Am Coll Cardiol 1995;25: 466-474.